BR112016028066A2 - composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira - Google Patents

composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira

Info

Publication number
BR112016028066A2
BR112016028066A2 BR112016028066A BR112016028066A BR112016028066A2 BR 112016028066 A2 BR112016028066 A2 BR 112016028066A2 BR 112016028066 A BR112016028066 A BR 112016028066A BR 112016028066 A BR112016028066 A BR 112016028066A BR 112016028066 A2 BR112016028066 A2 BR 112016028066A2
Authority
BR
Brazil
Prior art keywords
ridessuis
idessuis
composition
antibody
protein
Prior art date
Application number
BR112016028066A
Other languages
English (en)
Inventor
BAUMS Christoph
Seele Jana
Valentin-Weigand Peter
Original Assignee
Idt Biologika Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50846835&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112016028066(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idt Biologika Gmbh filed Critical Idt Biologika Gmbh
Publication of BR112016028066A2 publication Critical patent/BR112016028066A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

é descrita uma composição de vacina compreendendo uma quantidade eficaz de pelo menos um polipeptídeo selecionado a partir do grupo de idessuis, ridessuis, um análogo ou um fragmento destes, ou um polinucleotídeo que codifica os mesmos. essa composição de vacina é utilizada para tratamento profilático, metafilático ou terapêutico de uma infecção por streptococcus suis em suínos ou seres humanos.
BR112016028066A 2014-05-30 2015-05-29 composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira BR112016028066A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14170637.4A EP2949340A1 (en) 2014-05-30 2014-05-30 Vaccine composition against Streptococcus suis infection
PCT/EP2015/061961 WO2015181356A1 (en) 2014-05-30 2015-05-29 Vaccine composition against streptococcus suis infection

Publications (1)

Publication Number Publication Date
BR112016028066A2 true BR112016028066A2 (pt) 2017-10-24

Family

ID=50846835

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016028066A BR112016028066A2 (pt) 2014-05-30 2015-05-29 composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira

Country Status (20)

Country Link
US (3) US20170209561A1 (pt)
EP (3) EP2949340A1 (pt)
JP (2) JP6670304B2 (pt)
KR (1) KR102480824B1 (pt)
CN (2) CN113769076A (pt)
AU (1) AU2015265884B2 (pt)
BR (1) BR112016028066A2 (pt)
CA (1) CA2947798A1 (pt)
DE (1) DE202015009979U1 (pt)
DK (1) DK3148576T3 (pt)
ES (1) ES2846698T3 (pt)
HU (1) HUE053084T2 (pt)
MX (1) MX2016015821A (pt)
MY (1) MY178365A (pt)
NZ (1) NZ726364A (pt)
PL (1) PL3148576T3 (pt)
PT (1) PT3148576T (pt)
RU (1) RU2735101C2 (pt)
WO (1) WO2015181356A1 (pt)
ZA (1) ZA201607627B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017005913A1 (en) 2015-07-09 2017-01-12 Intervacc Ab Vaccine against s.suis infection
US20200038499A1 (en) * 2017-03-22 2020-02-06 Modernatx, Inc. Rna bacterial vaccines
EP3661546B1 (en) * 2017-08-03 2023-12-13 Intervet International B.V. A vaccine for protection against streptococcus suis
AU2018325528A1 (en) 2017-08-31 2020-04-16 Newport Laboratories, Inc. Streptococcus suis vaccines to protect against reproductive, nursery-age, and growing pig diseases and methods of making and use thereof
WO2019115743A1 (en) 2017-12-15 2019-06-20 Intervet International B.V. A vaccine for protection against streptococcus suis
JP2021506782A (ja) * 2017-12-15 2021-02-22 インターベット インターナショナル ベー． フェー． レンサ球菌感染防御のためのワクチン
US20220339276A1 (en) * 2017-12-15 2022-10-27 Intervet Inc. A vaccine for protection against streptococcus suis
EP3549600A1 (en) * 2018-04-03 2019-10-09 Intervet International B.V. A vaccine for protection against streptococcus suis
KR102073086B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-1 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
JP7295223B2 (ja) * 2018-08-27 2023-06-20 インターベット インターナショナル ベー． フェー． 混合ワクチン
CN112969475A (zh) * 2018-11-08 2021-06-15 英特维特国际股份有限公司 用于保护猪对抗猪链球菌的疫苗
WO2020104640A1 (en) 2018-11-23 2020-05-28 Intervet International B.V. A vaccine for protection against streptococcus suis
KR102524577B1 (ko) * 2019-04-22 2023-04-21 전남대학교산학협력단 플라젤린 융합 단백질 및 이의 용도
WO2021073778A1 (en) 2019-10-14 2021-04-22 Ceva Sante Animale Compositions and methods for vaccinating piglets against streptococcus
US20220378900A1 (en) 2019-11-20 2022-12-01 Intervet Inc. A novel vaccine against heamophilus parasuis
EP4061414A1 (en) 2019-11-20 2022-09-28 Intervet International B.V. A novel vaccine against heamophilus parasuis
EP4061415A1 (en) 2019-11-20 2022-09-28 Intervet International B.V. A novel vaccine against heamophilus parasuis
WO2021185680A1 (en) 2020-03-14 2021-09-23 Intervet International B.V. A vaccine for protection against streptococcus suis serotype 9, sequence type 16
CN112410310A (zh) * 2020-10-28 2021-02-26 天津农学院 一种猪链球菌疫苗重组蛋白gse及其制备方法和应用
CN113444694B (zh) * 2021-06-22 2022-09-30 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种噬菌体sp2019-lx株及其在制备腺疫治疗性药物中的应用
CN113332421B (zh) * 2021-07-02 2022-07-19 江苏省农业科学院 一种猪链球菌病疫苗
CN117794563A (zh) 2021-08-03 2024-03-29 英特维特国际股份有限公司 用于保护以对抗多种血清型的猪链球菌的疫苗
CN117794564A (zh) 2021-08-03 2024-03-29 英特维特国际股份有限公司 用于保护以对抗多种血清型的猪链球菌的疫苗
WO2023011811A1 (en) 2021-08-03 2023-02-09 Intervet International B.V. A vaccine for protection against streptococcus suis of various serotypes
WO2023088988A1 (en) 2021-11-18 2023-05-25 Intervet International B.V. A method to produce a vaccine against streptococcus suis and the said vaccine
WO2023203238A1 (en) * 2022-04-22 2023-10-26 Intervacc Ab Streptococcus suis vaccine composition comprising immunogenic fusion polypeptides
WO2024112492A1 (en) * 2022-11-22 2024-05-30 Duke University Compositions comprising antibody cleaving enzymes and method of using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
ID27482A (id) * 1998-02-20 2001-04-12 Iaf Biochem Int Antigen streptococcus kelompok b
BR0208874A (pt) * 2001-04-13 2004-06-22 Wyeth Corp Proteìnas superficiais de streptococcus pyogenes
DE10239629A1 (de) * 2002-08-23 2004-04-08 Idt Impfstoffwerk Dessau-Tornau Gmbh Nicht-rekombinate Subunit-Vakzine gegen Streptococcus suis-Infektionen des Schweines
ES2581981T3 (es) * 2005-09-02 2016-09-08 Valorisation-Recherche, Limited Partnership Polipéptidos de Streptococcus suis y polinucleótidos codificantes de los mismos y su utilización en aplicaciones vacunales y diagnósticas
NZ586367A (en) * 2007-12-13 2012-04-27 Intervacc Ab Improved immunizing composition comprising an antigen from Streptococcus equi
TW201043242A (en) * 2009-03-26 2010-12-16 Intervet Int Bv Vaccine for protection against Streptococcus suis bacteria of various serotypes
AU2011258898B2 (en) * 2010-05-26 2015-05-07 Intervacc Ab Vaccine against Streptococcal infections based on recombinant proteins
WO2019115743A1 (en) 2017-12-15 2019-06-20 Intervet International B.V. A vaccine for protection against streptococcus suis

Also Published As

Publication number Publication date
JP6909268B2 (ja) 2021-07-28
DK3148576T3 (da) 2021-01-18
AU2015265884A1 (en) 2016-12-08
ES2846698T3 (es) 2021-07-28
PT3148576T (pt) 2021-02-01
RU2016146801A3 (pt) 2018-12-10
JP2020019816A (ja) 2020-02-06
MX2016015821A (es) 2017-04-25
JP6670304B2 (ja) 2020-03-18
EP3795174A1 (en) 2021-03-24
US20210015910A1 (en) 2021-01-21
CN106561082B (zh) 2021-08-03
EP3148576B8 (en) 2020-12-30
MY178365A (en) 2020-10-09
KR20170005855A (ko) 2017-01-16
WO2015181356A1 (en) 2015-12-03
EP3148576B1 (en) 2020-10-28
EP2949340A1 (en) 2015-12-02
DE202015009979U1 (de) 2022-05-23
PL3148576T3 (pl) 2021-05-04
KR102480824B1 (ko) 2022-12-22
US20220401543A1 (en) 2022-12-22
WO2015181356A8 (en) 2016-12-22
NZ726364A (en) 2023-05-26
RU2735101C2 (ru) 2020-10-28
ZA201607627B (en) 2020-09-30
US20170209561A1 (en) 2017-07-27
HUE053084T2 (hu) 2021-06-28
JP2017518367A (ja) 2017-07-06
CN113769076A (zh) 2021-12-10
RU2016146801A (ru) 2018-05-29
AU2015265884B2 (en) 2021-03-04
CN106561082A (zh) 2017-04-12
EP3148576A1 (en) 2017-04-05
CA2947798A1 (en) 2015-12-03

Similar Documents

Publication Publication Date Title
BR112016028066A2 (pt) composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira
CO2017006580A2 (es) Anticuerpos humanos para hemaglutinina de influenza
BR112018074463A2 (pt) anticorpos anti-tim-3 e métodos de uso dos mesmos.
BR112017008165A2 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
BR112016025009A2 (pt) anticorpos humanos para a síndrome respiratória do oriente médio - proteína de superfície
BR112019000327A8 (pt) Anticorpo para anticlaudina 18a2 e uso do mesmo
CY1120729T1 (el) Πεπτιδια και συνθεσεις για τη θεραπεια τραυματισμου των αρθρωσεων
BR112019001737A2 (pt) expressão de pten-long com vírus oncolíticos
BR112017023646A2 (pt) proteínas agonistas de receptor de cd40 de cadeia simples
BR112018007017A2 (pt) polipeptídeos
BR112016028288A2 (pt) ?composto, composição farmacêutica, métodos para tratamento de um indivíduo com uma doença ou condição e para inibir a quinase, e, uso de um composto?
BR112018006251A2 (pt) anticorpos antagonistas que se ligam especificamente a cd40 humano e métodos de uso
BR112015031475A2 (pt) composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto.
BR112016022814A8 (pt) composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico
BR112016023979A2 (pt) métodos de melhora ou aceleração da recuperação física após cirurgia para fratura óssea
BR112015029788A2 (pt) hetero-multímero, construto de anticorpo isolado, ácido nucleico, célula hospedeira, método para preparar o hetero-multímero, composição farmacêutica, método para tratar uma doença, uso do hetero-multímero, uso de uma quantia terapêutica do hetero-multímero e método para reduzir a função efetora de um construto de anticorpo
BR112018072723A2 (pt) composição, e, métodos para tratar uma doença em um sujeito e para aumentar uma resposta imunológica em um sujeito
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
BR112016024515A2 (pt) proteínas do agonista do receptor trail de cadeia única
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
CL2016002794A1 (es) Vacuna de péptido que comprende un péptido ras mutante y un agente quimioterapéutico
BR112017023131A2 (pt) anticorpos anti- fcrn
BR112017011556A2 (pt) métodos para gerar um anticorpo sintético, prevenir ou tratar uma doença, tratar um sujeito de infecção por um patógeno e um sujeito com câncer, produto, molécula de ácido nucleico, e, composição.
BR112018006006A2 (pt) receptores de antígeno, cadeias peptídicas, células recombinantes, métodos para produzir uma célula que expressa um receptor de antígeno e para o tratamento de uma doença, ácidos nucleicos e composição farmacêutica
BR112018002319A2 (pt) anticorpos anti-cd154 e métodos de uso dos mesmos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: CEVA SANTE ANIMALE S.A. (FR)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]